# Low-Dose Enoxaparin in Psoriasis

> **NCT06416566** · NA · NOT_YET_RECRUITING · sponsor: **Zagazig University** · enrollment: 30 (estimated)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Subcutaneous Enoxaparin

## Key facts

- **NCT ID:** NCT06416566
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-05-15
- **Primary completion:** 2024-09-01
- **Final completion:** 2024-10-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06416566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06416566, "Low-Dose Enoxaparin in Psoriasis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06416566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*